UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049996
Receipt number R000056942
Scientific Title Evaluate hair growth effect by long-term use of study sample
Date of disclosure of the study information 2023/01/10
Last modified on 2023/07/12 14:17:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Hair growth trial

Acronym

Hair growth trial

Scientific Title

Evaluate hair growth effect by long-term use of study sample

Scientific Title:Acronym

Hair growth trial

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the hair growth effect of the study sample in healthy adult women who are worried about thinning hair in an 18-week repeated dose topical administration study.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Photo Trichogram (Hair number, Hair growth rate, Hair diameter, Anagen hair percentage)

Key secondary outcomes

Photography of area at top of head and investigation of adverse event


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

The study sample is applied twice daily to the scalp in prescribed amounts for 18 weeks.

Interventions/Control_2

Placebo is applied twice daily to the scalp in prescribed amounts for 18 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

69 years-old >=

Gender

Female

Key inclusion criteria

1. Healthy Japanese females aged 40 to 69 at the time of informed consent
2. Subjects who is worried about thinning hair and hair loss
3. Subjects who agree to keep the conditions such as hair conditioning and hair dyeing constant on each visiting day
4. Subjects who agree to cut hair locally approximately 1.0 cm x 1.0 cm near the crown on each visiting day
5. Subjects who have signed a consent at own discretion before the start of the study

Key exclusion criteria

1. Subjects with pathological hair loss such as alopecia areata
2. Subjects with scalp diseases other than hair loss (eg, head eczema, seborrheic eczema, psoriasis, tinea capitis, and other scalp infections)
3. Subjects who regularly apply external application or take oral medicines, supplements, etc. that may affect the condition of the head
4. Subjects with a history of hypersensitivity (allergies) to hair growth agents, hair restorer, cosmetics (shampoo, etc.), or hypersensitivity to other medicines.
5. Subjects who have used existing hair growth agents and hair restorer within the past 2 months, regardless of whether they are pharmaceutical products or quasi-drugs.
6. Subjects who regularly use wigs during the study period, subjects who have undergone hair transplantation or hair growth, or subjects who are scheduled during the study period
7. Subjects currently using medications known to cause trichotillomania or hirsutism (eg, phenytoin for epilepsy)
8. Subjects undergoing hormone replacement therapy or taking oral contraceptives
9. Subjects who are pregnant or lactating, or who intend to become pregnant
10. Subjects who have participated in another clinical study within the past month or those who plan to participate during the study period
11. Subjects judged inappropriate for this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Sawamoto

Organization

Shukugawa Sawamoto Hifuka

Division name

Shukugawa Sawamoto Hifuka

Zip code

662-0977

Address

11-3, Kagura-cho, Nishinomiya City, Hyogo, Japan

TEL

0798-37-1112

Email

sawamoto0908@yahoo.co.jp


Public contact

Name of contact person

1st name Ayaka
Middle name
Last name Taniguchi

Organization

R&D Center, Nikko Chemicals Co., Ltd.

Division name

under constraction

Zip code

541-0052

Address

1-6-14 Azuchimachi,Chuo-ku,Osaka City, Osaka, Japan

TEL

080-4249-0198

Homepage URL


Email

volunteer@nikkolgroup.com


Sponsor or person

Institute

Nikoderm Research Inc.

Institute

Department

Personal name



Funding Source

Organization

Tsuno Rice Fine Chemicals Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

under constraction

Address

1-6-14 Azuchimachi,Chuo-ku,Osaka City, Osaka, Japan

Tel

06-6125-3501

Email

myamamura@nikkolgroup.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 01 Month 10 Day

Date of IRB

2023 Year 01 Month 24 Day

Anticipated trial start date

2023 Year 01 Month 31 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 01 Month 09 Day

Last modified on

2023 Year 07 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056942


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name